1. Home
  2. Labeler Index
  3. Astrazeneca Pharmaceuticals Lp
  4. 0310-2830
  5. NDC Package Code: 0310-2830-00 Benralizumab

NDC Package 0310-2830-00 Benralizumab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0310-2830-00
Package Description:
46.7 kg in 1 BAG
Product Code:
0310-2830
Non-Proprietary Name:
Benralizumab
Substance Name:
Benralizumab
Usage Information:
Benralizumab is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
00310283000
Product Type:
Bulk Ingredient
Labeler Name:
Astrazeneca Pharmaceuticals Lp
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s):
  • BENRALIZUMAB 46.7 kg/46.7kg
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
    Start Marketing Date:
    02-04-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0310-2830-00?

    The NDC Packaged Code 0310-2830-00 is assigned to an UNFINISHED drug package of 46.7 kg in 1 bag of Benralizumab, a bulk ingredient labeled by Astrazeneca Pharmaceuticals Lp. The product's dosage form is liquid and is administered via form.

    Is NDC 0310-2830 included in the NDC Directory?

    Yes, Benralizumab is an UNFINISHED PRODUCT with code 0310-2830 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Pharmaceuticals Lp on February 04, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0310-2830-00?

    The 11-digit format is 00310283000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20310-2830-005-4-200310-2830-00